SuperworthNatural Alternatives International EPS NAII
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$3.42
- Latest quarter, Q4 FY26
- −$2.23
- Fiscal year 2026
- −$3.42
Natural Alternatives International's earnings per share was −$3.42 over the twelve months to Jun 30, 2026.
In its latest quarter, Q4 FY26, it was −$2.23.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | −$3.42 | n/a |
| FY2025 | −$2.27 | n/a |
| FY2024 | −$1.23 | −386% |
| FY2023 | $0.43 | −75% |
| FY2022 | $1.74 | +3% |
| FY2021 | $1.69 | n/a |
| FY2020 | −$0.26 | −128% |
| FY2019 | $0.92 | +28% |
| FY2018 | $0.72 | −33% |
| FY2017 | $1.08 | −25% |
| FY2016 | $1.44 | +188% |
| FY2015 | $0.50 | +72% |
| FY2014 | $0.29 | +26% |
| FY2013 | $0.23 | −61% |
| FY2012 | $0.59 | −18% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY26 | −$2.23 | n/a | −$3.42 | |
| Q3 FY26 | −$0.72 | n/a | −$2.39 | |
| Q2 FY26 | −$0.42 | n/a | −$2.04 | |
| Q1 FY26 | −$0.05 | n/a | −$1.99 | |
| Q4 FY25 | −$1.20 | n/a | −$2.27 | |
| Q3 FY25 | −$0.37 | n/a | −$1.39 | |
| Q2 FY25 | −$0.37 | n/a | −$1.29 | |
| Q1 FY25 | −$0.33 | n/a | −$1.44 | |
| Q4 FY24 | −$0.32 | −191% | −$1.23 | |
| Q3 FY24 | −$0.27 | n/a | −$0.56 | |
| Q2 FY24 | −$0.52 | −268% | −$0.70 | |
| Q1 FY24 | −$0.12 | −167% | $0.13 |
Against its peers
Companies in Chemicals nearest Natural Alternatives International's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| NAIINatural Alternatives International | −$3.42 | |
| BTMDbiote | $0.10 | −89% a year |
| FTLFFitlife Brands | $0.62 | −23% a year |
| NAGENiagen Bioscience | $0.18 | −14% a year |
| Peer median | $0.18 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Natural Alternatives International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.